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Abstract
Background: Plasmodium falciparum antigenic diversity and polymorphism confuses the issue of
antimalarial vaccine development. Merozoite surface protein (MSP)-1 and -2 are two highly
polymorphic vaccine candidates. Characterisation of their precise polymorphism in endemic
regions may facilitate the design of an effective vaccine.
Methods: Isolates obtained in 52 Gabonese children presenting with uncomplicated malaria were
genotyped by nested-PCR of msp-1 block 2, and msp-2 block 3, to analyze both parasite population
polymorphism and clone fluctuations.
Results: Twenty-five and 19 different alleles were respectively obtained for msp-1 and msp-2 loci,
the RO33 family of msp-1 being poorly polymorphic. Four cases of non-random distribution of
alleles were reported of the FC27, and/or 3D7 families of msp-2. All but two isolates were
composed of more than one genotype, and the multiplicity of infection (MOI) was 4.0. Neither
parasite density nor age was related to MOI. Clone fluctuations were studied for ten subjects who
were sampled again at reappearance of parasites in blood. Disappearance and reappearance of
alleles were observed following treatment, suggesting difficulties in assessing polymorphism and in
distinguishing reinfection from recrudescence.
Conclusion: P. falciparum polymorphism is extensive in Southeast Gabon, and most of infections
are composed of multiple clones. The fluctuation of clones contributes to parasite diversity.
Background
One main limitation to the development of a vaccine
against Plasmodium falciparum is the antigenic diversity re-
lated to P. falciparum polymorphism. Merozoite surface
protein (MSP)-1 and MSP-2 are two proteins causing im-
mune response in humans [1–4] and are prime vaccine
candidates. Perhaps as part of an immune evasion mech-
anism, msp-119 and msp-2 DNA sequences include varia-
ble blocks generating antigenically diverse forms [4,5].
The polymorphism at these two loci is mainly assessed by
the number of repeats [6–8], which can be used to distin-
guish by size the different alleles after PCR amplification.
The phenomenon of clone fluctuation, which consists of
kinetic changes in the relative load of each parasite sub-
population present in blood [9,10], is important to con-
sider when studying P. falciparum diversity. Strain-specific
immunity is largely responsible for protective immunity
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to malaria parasites [11,12]. In malaria endemic areas, in-
fections due to multiple parasite clones are frequent
[11,13–16], and clone fluctuation may be a logical strate-
gy to slow down the appearance of strain-specific respons-
es. However, mechanisms other than immune evasion
may be involved in peripheral blood genotypes' fluctua-
tions, including sequestration in the deep vasculature,
strain competition, and clearance effect related to either
strain-specific immune response or treatment.
Allelic diversity and clone fluctuation have rarely been as-
sessed in the same study, although their concomitant ex-
istence highly complicates the analysis of P. falciparum
polymorphism. We studied both mechanisms in P. falci-
parum-infected children from Gabon and discuss the im-
plications of our findings.
Subjects and Methods
Study area and blood collection
Bakoumba, a village from southeast Gabon in the Haut-
Ogooué province, belongs to a meso- to hyper-endemic
area for P. falciparum malaria [17]. The average EIR for
February and March 2000, the time of the study, was 0.83
infective bite per man per night, due to Anopheles gambiae,
Anopheles funestus, and Anopheles moucheti (Elissa et al.,
personal communication). Samples were collected during
a treatment efficacy study of sulfadoxine-pyrimethamine
combination and amodiaquine carried out between Janu-
ary and June 2000 [18]. This study involved 252 subjects
aged between six months and 10 years. Patients were fol-
lowed weekly during four weeks after treatment (Day 0),
as well as any other day if the child was unwell. At enrol-
ment, and during the follow-up, finger-prick blood was
sampled for thick smears and collection on filter paper.
Patients involved in the present study were the 52 chil-
dren in which treatment failed, and for which multiple
parasitised blood samples were available. Ethical clear-
ance was given by the Ethics Committee of the Interna-
tional Centre for Medical Research of Franceville, and
informed consent was obtained from parents or
guardians.
DNA preparation and PCR amplification
Blood collected on filter-paper was dried and conserved at
room temperature until extraction. DNA was prepared by
chelex extraction, as described [19], and stored at -20° C.
The oligonucleotides primers were designed from pub-
lished sequences, as listed in the Nucleotide Blast Data-
base, to amplify block 2 of msp-1 [20], and block 3 of msp-
2 [5]. The two genes were amplified by nested PCR, each
amplification with conserved, or family-specific primer
pair, being done separately, as described [18]. PCR prod-
ucts were electrophoresed on 1.5% agarose gels, and DNA
visualized by ultraviolet transillumination after ethidium
bromide staining. Fragments obtained were compared by
size. For comparison, purified genomic DNA from W2,
HB3 and 3D7 laboratory strains were amplified and elec-
trophoresed similarly. All migrations were repeated at
least twice.
Data analysis
The multiplicity of infection (MOI), or number of geno-
types per infection, was calculated as the highest number
of genotypes at any of the two MSP loci. Relations be-
tween the MOI and age or parasite density were studied
using the Spearman correlation test. The prevalence of
each family was calculated as the percentage of D0 sam-
ples containing allele(s) of this family. The distribution of
the specific families was estimated at each of the two loci
as the percentage of fragments assigned to one family
within the overall number of fragments. The occurrence of
specific associations of paired alleles was analysed by the
Fisher's exact test.
Results
Samples and genotyping strategy
Fifty-two samples collected at enrolment were used for de-
scribing parasite allelic diversity. Additional samples were
collected from the same subjects, at first reappearance of
parasites in blood, 7 to 21 days following treatment. In 10
subjects, a third sample was obtained 5 to 14 days later. Fi-
nally, a fourth sample was available from one subject. All
genotyped samples were positive for msp-1  and  msp-2
PCR.
P. falciparum allelic diversity
Among the 52 D0 samples, at the msp-1 locus, 14 alleles
of the K1 family ranged from 135 to 330 bp; 8 MAD20 al-
leles ranged from 190 to 280 bp; and 3 of the RO33 family
were of 160, 230, and 250 bp (table 2). For the msp-2 lo-
cus, 11 FC27 alleles ranged from 300 to 600 bp; and 8
3D7 alleles ranged from 360 to 590 bp. Forty-seven
(90.4%) D0 samples harboured K1 parasites, 33 (63.5%)
MAD20 parasites, and 19 (36.5%) RO33 parasites. For
msp-2, 34 (65.4%) isolates contained FC27 parasites, and
43 (82.7%) 3D7 parasites. At each locus, family distribu-
tion was 52.5%, 32.5%, and 15.0% for K1, MAD20, and
RO33 of msp-1; and 49.7% and 50.3% for FC27 and 3D7
of msp-2. Four specific associations of two alleles were
over-represented. In the FC27 family, the 500 and 560 bp
(P = 0.004), and the 530 and 600 bp alleles (P < 0.0001)
were positively associated. In the 3D7 family, the 500 bp
allele was associated positively to the 560 bp allele (P =
0.01) and negatively to the 530 bp allele (P = 0.01).
Multiplicity of infection
Before treatment, MOI (± SE) was 4.0 (± 0.26). All but two
samples contained at least two distinct parasite lines. The
two single clonal infections were composed by parasites
belonging to the K1 family of msp-1, and to the FC27 andMalaria Journal 2003, 2 http://www.malariajournal.com/content/2/1/12
Page 3 of 6
(page number not for citation purposes)
3D7 family of msp-2, respectively. MOI was not correlated
to age (Figure 1, Spearman correlation, P > 0.1), although
the number of genotypes of the K1 family increased with
age (Spearman correlation, P = 0.04).
Clonal fluctuations
Following treatment, parasites reappeared in the blood of
10 children in which 2 or 3 additional blood samples
were obtained. Three types of fluctuating figures of msp-1
and msp-2 molecular patterns were obtained (Figure 2). In
type a, one or several initial allele(s) transiently vanished
and recurred thereafter. In type b, new alleles appeared at
intermediate and/or final points, although some initial al-
leles may persist. In type c, alleles observed at intermedi-
ate and final points were all present at D0. Variations in
parasite densities were not related to appearance or disap-
pearance of alleles (Spearman test for MOI and parasite
density, P > 0.1). The disappearance of alleles, as in type
c, could be attributed to treatment efficacy, and cannot be
considered as parasite fluctuation. Recurrent parasites
with identical genotype as initial parasites are likely drug-
resistant parasites. Among the 5 families of msp-1 and msp-
2 genes, a or b fluctuating types were observed in 9 of the
10 children. The figure of the child n° 170 was of type c
for all 5 families.
Discussion
This work investigated the polymorphism of P. falciparum
subpopulations in Gabon, by nested-PCR typing. This
method does not allow one to distinguish alleles of iden-
tical size, but differing in sequences [20]. Competition be-
tween alleles during PCR amplification has previously
been described [21]. Identical field samples were geno-
typed in different laboratories [22], and the main differ-
ence lied in the number of alleles detected. Our parasite
Table 1: Sequences of oligonucleotide primers used to amplify merozoite surface protein (msp)-1 and msp-2 polymorphic regions of 
Plasmodium falciparum isolates from Gabon.
Gene Primer Sequence Notes
msp1-C1 5'-AAGCTTTAGAAGATGCAGTATTGAC Conserved
msp1-C2 5'-ATTCATTAATTTCTTCATATCCATC Conserved
K1a 5'-GAAATTACTACAAAAGGTGCAAGTG K1 family-specific
msp-1 K1b 5'-AGATGAAGTATTTGAACGAGGTAAAGTG K1 family-specific
MAD20a 5'-AAATGAAGGAACAAGTGGAACAGCTGTTAC MAD20 family-specific
MAD20b 5'-ATCTGAAGGATTTGTACGTCTTGAATTACC MAD20 family-specific
RO33a 5'-TAAAGGATGGAGCAAATACTCAAGTTGTTG RO33 family-specific
RO33b 5'-CATCTGAAGGATTTGCAGCACCTGGAGATC RO33 family-specific
msp2-C1 5'-ATGAAGGTAATTAAAACATTGTCTATTATA Conserved
msp2-C2 5'-CTTTGTTACCATCGGTACATTCTT Conserved
msp-2 FC27a 5'-GCAAATGAAGGTTCTAATACTAATAG FC27 family-specific
FC27b 5'-GCTTTGGGTCCTTCTTCAGTTGATTC FC27 family-specific
3D7a 5'-AGAAGTATGGCAGAAAGTAAGCCTCCTACT 3D7 family-specific
3D7b 5'-GATTGTAATTCGGGGGATTCAGTTTGTTCG 3D7 family-specific
Figure 1
Mean number of genotypes in merozoite surface protein 
(msp)-1 and -2 polymorphic families of Plasmodium falciparum 
collected in the blood of 52 children, 0 to 95 months old, 
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isolates, as most field samples, contained several clones
with polymorphic msp-1 and msp-2 sequences at the vari-
able blocks that may differ considerably in size, nucle-
otide sequence, and repeat copy number [7,23]. In such
conditions, nested-PCR remains a suitable method to
study msp polymorphism. Nevertheless, the results should
be considered with the method limitations in mind, as
variations in sensitivity were seen throughout experi-
ments for weak bands, as well as in the estimation of
band's length. When the same samples were electro-
phoresed several times, faint bands were inconsistently
visible, demonstrating variations in technique sensitivity,
due to unmanageable changes in temperature or moisture
content. Estimation of band's length was liable to dispar-
ities between and within gels. Given these limitations, it is
important to replicate all PCR products migrations.
This study showed high allelic diversity, as 25 and 19 dif-
ferent alleles were respectively present at the msp-1 and
msp-2 loci. However, the RO33 family of msp-1 was poorly
Figure 2
Examples of clonal fluctuations in successive blood samples between Day 0 and Day 28. The different clonal fluctuation figures 
were classified by type a, b, or c. Type a: one or several of the initial allele(s) transiently vanished, and were present again at the 
final point. Type b: new alleles appeared at intermediate and/or final points, although some of the initial alleles may be still 
present. Type c: alleles observed at intermediate and final points were all present at D0.
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polymorphic, with only 3 different alleles detected. At the
msp-2 locus, FC27 and 3D7 alleles were nearly equally dis-
tributed, whereas alleles belonging to the K1 family were
more frequent at the msp-1 locus. This situation differs
from that of Dienga [13], a village from the same area of
Gabon (both villages being 45 km apart), where the R033
family was the most frequent at the msp-1 locus in isolates
from asymptomatic subjects. However, a single RO33 al-
lele was detected, confirming the reduced polymorphism
of this family. In a more recent study in Dienga [24],
RO33 and FC27 alleles were mainly found during asymp-
tomatic infections, whereas K1, MAD20, and 3D7 were
predominant in isolates from clinical infections. Such a
differential distribution according to clinical status was
not observed in Cameroonian [24], Senegalese [14], nor
Kenyan [25] isolates. In Senegal [14] and Thailand [26],
the RO33 family was poorly polymorphic, as opposed to
the other MSP-1 and MSP-2 families. The msp-2 locus is
usually highly polymorphic, and FC27 and 3D7 families
are both highly represented [14,26,27].
Multiple bands were observed in all but two samples, and
the MOI was 4.0, probably as a consequence of the high
transmission level [14,27]. The very high MOI may also be
explained by the clinical and immunological status of the
patients, although conflicting results are present in the lit-
erature. Some studies indicated that MOI decreases with
age in asymptomatic subjects after 15 years [28,29]. In our
study, age was not related to the number of genotypes, in
agreement with several studies achieved with symptomat-
ic or asymptomatic subjects [14–16].
Ten subjects were studied at multiple points during four
weeks. In nine, alleles fluctuated with time. Either alleles
transiently disappeared, or additional alleles appeared
(and eventually disappeared) during the follow up. We
cannot rule out that clonal disappearance was the result of
treatment activity, and its reappearance due to reinfection
by a new anopheles bite. However, parasite population
showed a very rich polymorphism of msp-1 and msp-2 loci
composed of at least 22 different alleles, with the most
common allele not exceeding 28% of all alleles of a given
family. The concomitant reinfection by several clones sim-
ilar to those present in the initial infection would be very
unlikely. Alleles fluctuations were more likely related to
variations of the alleles ratios in peripheral blood, as re-
ported over a several months period in the absence of ma-
laria transmission [30]. In holoendemic areas, Daubersies
et al. [9] concluded that a rapid turnover of parasite pop-
ulations inoculated by mosquitoes has occurred, whereas
Farnert et al. [10] suggested fluctuations of inherently syn-
chronous subpopulations. Several mechanisms may be
involved including sequestration in the deep vasculature,
strain competition, strain-specific immune response, and/
or parasite immune evasion. In our study, treatment
efficacy is also responsible for the disappearance of sensi-
tive clones, and drug-resistance is liable for recrudescent
parasites. The appearance of new allele(s) could be attrib-
uted to reinfection by new clone(s), or to detection of gen-
otype(s) present earlier at undetectable concentration.
Clonal fluctuation causes huge difficulties in determining
the precise composition of a parasite population. PCR dis-
tinction between recrudescent and newly inoculated para-
sites is critical in treatment efficacy studies. Only
recrudescent clones can be warranted, while reinfections
cannot be ascertained.
Conclusions
Although the method had showed limitations, this study
illustrated high polymorphism in Southeast Gabon with
respectively 25 and 19 different alleles at msp-1 and msp-2
loci. Infections were highly complex, malaria attacks be-
ing characterized by a mean of four genotypes per infec-
tion. Clonal fluctuation increases infection complexity
and makes polymorphism analysis difficult. These results
illustrate two forms of P. falciparum complexity in a high
transmission area: sequence polymorphism and clonal
fluctuation.
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